Literature DB >> 17623561

Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy.

Dolly Baliunas1, Jayadeep Patra, Jürgen Rehm, Svetlana Popova, Murray Kaiserman, Benjamin Taylor.   

Abstract

Cigarette smoking is one of the most important risk factors for burden of disease. Our objective was to estimate the smoking-attributable deaths and the years of life lost for Canada 2002. For Canada in 2002, 37,209 of all deaths aged 0 to 80+ years were attributable to smoking, 23,766 in men and 13,443 in women. This constituted 16.6 percent of all deaths in Canada, 21 percent for men and 12.2 percent for women. Main causes of smoking-attributable death were malignant neoplasms (17,427), cardiovascular diseases (CVD) (10,275) and respiratory diseases (8,282). Lung cancer (13,401) and chronic obstructive pulmonary disease (COPD) (7,533) were the single largest disease contributors to deaths caused by smoking. 515,608 years of life were lost prematurely in Canada in that year, 316,417 years in men and 199,191 years in women. Cigarette smoking is a major contributor to mortality in Canada and its impact on Canadian society continues to be an unacceptable burden.

Entities:  

Mesh:

Year:  2007        PMID: 17623561

Source DB:  PubMed          Journal:  Chronic Dis Can        ISSN: 0228-8699


  15 in total

1.  Avoidable burden of disease: conceptual and methodological issues in substance abuse epidemiology.

Authors:  Jürgen Rehm; Benjamin Taylor; Jayadeep Patra; Gerhard Gmel
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

2.  Substance-attributable morbidity and mortality changes to Canada's epidemiological profile: measurable differences over a ten-year period.

Authors:  Jayadeep Patra; Benjamin Taylor; Jürgen T Rehm; Dolly Baliunas; Svetlana Popova
Journal:  Can J Public Health       Date:  2007 May-Jun

3.  Cohort Profile: The Nicotine Dependence in Teens (NDIT) Study.

Authors:  Jennifer O'Loughlin; Erika N Dugas; Jennifer Brunet; Joseph DiFranza; James C Engert; Andre Gervais; Katherine Gray-Donald; Igor Karp; Nancy C Low; Catherine Sabiston; Marie-Pierre Sylvestre; Rachel F Tyndale; Nathalie Auger; Nathalie Auger; Belanger Mathieu; Barnett Tracie; Michael Chaiton; Meghan J Chenoweth; Evelyn Constantin; Gisèle Contreras; Lisa Kakinami; Aurelie Labbe; Katerina Maximova; Elizabeth McMillan; Erin K O'Loughlin; Roman Pabayo; Marie-Hélène Roy-Gagnon; Michèle Tremblay; Robert J Wellman; Andraeavan Hulst; Gilles Paradis
Journal:  Int J Epidemiol       Date:  2014-07-13       Impact factor: 7.196

4.  Initial uptake of the Ontario Pharmacy Smoking Cessation Program: Descriptive analysis over 2 years.

Authors:  Lindsay Wong; Andrea M Burden; Yan Yun Liu; Mina Tadrous; Nedzad Pojskic; Lisa Dolovich; Andrew Calzavara; Suzanne M Cadarette
Journal:  Can Pharm J (Ott)       Date:  2015-01

5.  Smokers' support for tobacco endgame measures in Canada: findings from the 2016 International Tobacco Control Smoking and Vaping Survey.

Authors:  Janet Chung-Hall; Geoffrey T Fong; Pete Driezen; Lorraine Craig
Journal:  CMAJ Open       Date:  2018-09-28

6.  Smoking behaviours among heterosexual and sexual minority youth? Findings from 15 years of provincially representative data.

Authors:  Jessica N Fish; Ryan J Watson; Jacqueline Gahagan; Carolyn M Porta; Dominic Beaulieu-Prévost; Stephen T Russell
Journal:  Drug Alcohol Rev       Date:  2018-11-26

Review 7.  Best practices for smoking cessation interventions in primary care.

Authors:  Andrew McIvor; John Kayser; Jean-Marc Assaad; Gerald Brosky; Penny Demarest; Philippe Desmarais; Christine Hampson; Milan Khara; Ratsamy Pathammavong; Robert Weinberg
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

Review 8.  Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.

Authors:  David Crockford; Donald Addington
Journal:  Can J Psychiatry       Date:  2017-09       Impact factor: 4.356

9.  Use of the zebrafish larvae as a model to study cigarette smoke condensate toxicity.

Authors:  Lee D Ellis; Evelyn C Soo; John C Achenbach; Michael G Morash; Kelly H Soanes
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

10.  Socioeconomic and geographic patterning of smoking behaviour in Canada: a cross-sectional multilevel analysis.

Authors:  Daniel J Corsi; Scott A Lear; Clara K Chow; S V Subramanian; Michael H Boyle; Koon K Teo
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.